Furthermore, the plasma IL-18 levels were positively correlated with the IFN-γ levels (r = 0.4761, P < 0.001) and the IL-6 levels (r = 0.2985, P < 0.01) in the AD patients (Figures 2(d) and 2(e)). This evidence concerns the gene IL6 and Alzheimer disease.